Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic hypofibrinolysis in complicated pregnancies.

Obstetrics and gynecology - 1 Jan 2001

Glueck C J, Kupferminc M J, Fontaine R N, Wang P, Weksler B B, Eldor A

Abstract excerpt

OBJECTIVE: To assess the hypofibrinolytic 4G/4G mutation of the plasminogen activator inhibitor (PAI-1) gene as a possible factor contributing to severe preeclampsia, abruptio placentae, fetal growth restriction, and stillbirth. METHODS: We compared 94 women from a previous report who had obstetric complications to 95 controls with normal pregnancies matched for ethnic background and age. We collected blood and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal Death
Share to Fetal Growth Retardation
Share to Fibrinolysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Israel

Share to Plasminogen Activator Inhibitor 1

Share to Pre-Eclampsia

Share to Thrombophilia

Source

Identifiers

PMID: 11152905
DOI: 10.1016/s0029-7844(00)01094-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic hypofibrinolysis in complicated pregnancies.PMID 11152905Read ↗

The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications.Semantic proximity Read ↗

Association of single nucleotide polymorphisms (4G/5G) of plasminogen activator inhibitor-1 and the risk factors for placenta-related obstetric complications.Semantic proximity Read ↗

Increased frequency of genetic thrombophilia in women with complications of pregnancy.Semantic proximity Read ↗

Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.Semantic proximity Read ↗

Association of plasminogen activator inhibitor-type 1 (-675 4G/5G) polymorphism with pre-eclampsia: systematic review.Semantic proximity Read ↗

The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 4G/5G gene polymorphism in women with fetal loss.Semantic proximity Read ↗

Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.Semantic proximity Read ↗

Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis.Semantic proximity Read ↗

Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome.Semantic proximity Read ↗

4G/5G variant of plasminogen activator inhibitor-1 gene and severe pregnancy-induced hypertension: subgroup analyses of variants of angiotensinogen and endothelial nitric oxide synthase.Semantic proximity Read ↗

Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.